-+ 0.00%
-+ 0.00%
-+ 0.00%

Changes in US stocks | Moderna (MRNA.US) raised its target price by many major Wall Street banks by more than 10%

Zhitongcaijing·08/25/2026 14:25:08
Listen to the news

The Zhitong Finance App learned that on Tuesday, Moderna (MRNA.US) stock price rose. As of press release, the stock had risen more than 10% to $153.3. According to the news, after the release of phase III clinical trial data for the individualized mRNA cancer vaccine jointly developed by Moderna and MRK.US (MRK.US), many institutions raised Moderna's target price. Barclays made a major adjustment to Moderna's price target, raising it sharply from the original $48 to $125. J.P. Morgan raised Moderna's price target from $40 to $77.